Doses to Normal Organs as Function of Administered Radioactivity
| mGy/MBq administered radioactivity | ||
| Tissue type | HER2-targeting | Nontargeting |
| Blood | 1.8 | 18.7 |
| Spleen | 150.0 | 36.6 |
| Liver | 27.1 | 15.4 |
| Kidneys | 9.4 | 15.0 |
Mean doses are presented under assumption that distribution of activity in therapy study follows biodistribution of HER2-targeting and nontargeting liposomes presented in Table 2.